Antipsychotic medications can help a person with bipolar disorder stabilize their moods, reduce agitation, and improve overall quality of life. Learn more about the medication types, dosage, side ...

Beloved TV star Madchen Amick has been talking about navigating her son Sly’s Bipolar 1 diagnosis together, and how in 2025, ...

He caught it really fast, and they changed that medication immediately and ... and downs in mood and energy,” often called “manic-depressive disorder” or “manic depression.” ...

Some have already tried numerous medications ... treating the mood disorder first until the patient is “stabilized.” Stabilized is the key word here, particularly if the patient is suicidal, manic, or ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.

If approved, CAPLYTA ® has the potential to be the first treatment approved for MDD and depressive symptoms associated with bipolar I and II in more than 15 years. Additional Phase 3 trials are ...

Friday morning and afternoon, officials conducted a deliberate — and sometimes difficult — serious mental illness hearing for ...

Award-winning author, Professor Paul Crawford tells us about how his latest novel, The Wonders of Doctor Bent, drew on the ...

A Cleveland Clinic psychiatrist discusses what the latest research suggests causes bipolar, what the individual experiences, ...

and depression, according to a longitudinal study published in JAMA Psychiatry in 2022. Medications used to treat these conditions can sometimes trigger a manic episode, particularly if there is a ...

JNJ-18038683 is under clinical development by Johnson & Johnson and currently in Phase II for Bipolar Disorder (Manic Depression). According to GlobalData, Phase II drugs for Bipolar Disorder (Manic ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...